SUN Pharmaceutical Industries Limited Vildagliptin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Vildagliptin Export Records India — #7 Exporter, 31 Shipments, $409.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vildagliptin

India Pharmaceutical Trade Intelligence

$10.2M178 Suppliers87 CountriesHS 30049099

ExportsIndia → FRANCE14.4%India → PORTUGAL10.1%

ImportsTURKEY → India$2110.6B SPAIN → India$164.0B

#1 Supplier: AJANTA PHARMA #1 Buyer: PLANET PHARMA

SUN Pharmaceutical Industries Limited — Vildagliptin Exporter #7 | $409.8K Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Vildagliptin Exporter Profile

Indian Pharmaceutical Exporter · #7 for Vildagliptin · $409.8K export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #7 Indian exporter of Vildagliptin with $409.8K in export value and 31 verified shipments. SUN Pharmaceutical Industries Limited holds a 4.0% market share in Vildagliptin exports across 5 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Vildagliptin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Vildagliptin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Vildagliptin?

Country	Value	Shipments	Share
BRAZIL	$167.3K	17	40.8%
SOUTH AFRICA	$139.3K	9	34.0%
MALAYSIA	$68.8K	3	16.8%
FRANCE	$23.2K	1	5.7%
ZIMBABWE	$11.2K	1

Who Are the Top Buyers of Vildagliptin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
RANBAXY PHARMACEUTICALS PTY LTD.,	SOUTH AFRICA	$112.1K	8
RANBAXY FARMACEUTICA LTDA	BRAZIL	$89.3K	8
RANBAXY FARMACEUTICA LTDA :	BRAZIL	$77.9K	3
RANBAXY(MALAYSIA)SDN.BHD..	MALAYSIA	$44.8K	2
M S RANBAXY PHARMACEUTICALS PTY LT	SOUTH AFRICA	$27.2K	1
RANBAXY MALAYSIA SDN BHD	MALAYSIA	$24.0K	1
PLANET PHARMA	FRANCE	$23.2K	1
M/S. PHARMACEUTICAL & CHEMICAL	ZIMBABWE	$11.2K	1
SUN FARMACEUTICA DO BRAZIL LTDA	BRAZIL	$73	6

SUN Pharmaceutical Industries Limited supplies Vildagliptin to 9 buyers globally. The largest buyer is RANBAXY PHARMACEUTICALS PTY LTD., (SOUTH AFRICA), followed by RANBAXY FARMACEUTICA LTDA (BRAZIL) and RANBAXY FARMACEUTICA LTDA : (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vildagliptin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
VILDAGLIPTIN TAB 50MG 6X10B BR EACH CONTAINS : VILDAGLIPTIN TAB 50MG PACK : Box60s	$77.9K	3
VILDAGLIPTIN TABLETS 50MG (EACH TABLETSCONTAINS: VILDAGLIPTIN 50MG) [13507 PACKS X60'S] B NO.PTF0631A, PTF0632A, PTF063	$49.2K	3
SUCRALO TAB 50MG CONTAINS VILDAGLIPTIN TAB SAP CODE : 1163494 BATCH : PTE5048A MFD : 12.12.2023 EXP : 30.11.2025NOS	$44.8K	2
VILEPTIN CO TABLETS 50/1000MG (EACH TABLET CONTAINS: VILDAGLIPTIN 50MG + METFORMIN HCL 1000MG) [7477 PACK X 6X10'S] (BAT	$32.8K	1
VILEPTIN CO TABS 50/1000MG E.TAB CONT.VILDAGLIPTIN 50MG,METFORMIN HCL 1000MG,Batch:PTG0335A,PTG0336A, PTG0337A,PTG0520AP	$31.1K	1
VILEPTIN CO TABS 50 1000MG EACH TAB CONTAINS VILDAGLIPTIN 50MG METFORMIN HCL 1000MG PACK SP Batch PTG1229A PTG1209	$27.2K	1
VILDAGLIPTIN TAB 50MG 6X10B BR EACH CONTAINS VILDAGLIPTIN TAB 50MG PACK Box60s	$25.1K	1
SUCRALO TAB 50MG VILDAGLIPTIN TABLETS 50 MG BATCH NO PTG1716A MFG DT 04 2025EXP DT 03 2027	$24.0K	1
VIDAGLIN TAB 50MG 3X10B FWA (VILDAGLIPTIN TABLETS) PACK: Box3x10s	$23.2K	1
VILEPTIN CO TABS 50/1000MG EACH TAB CONTAINS VILDAGLIPTIN 50MG,METFORMIN HCL 1000MG PACK : SP	$16.7K	2

SUN Pharmaceutical Industries Limited exports 23 distinct Vildagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VILDAGLIPTIN TAB 50MG 6X10B BR EACH CONTAINS : VILDAGLIPTIN with 3 shipments worth $77.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Vildagliptin Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	EMCURE PHARMACEUTICALS LIMITED	$984.8K	64	4	$15.4K
6	MICRO LABS LIMITED	$494.8K	15	8	$33.0K
7	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$409.8K	31	5	$13.2K
8	MACLEODS PHARMACEUTICALS LTD	$349.5K	14	2	$25.0K
9	AET LABORATORIES PRIVATE LIMITED	$331.5K	8	2	$41.4K

SUN Pharmaceutical Industries Limited ranks #7 among 178 Indian Vildagliptin exporters. Average shipment value of $13.2K compared to the market average of $42.0K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and MICRO LABS LIMITED.

Which Indian Ports Ship Vildagliptin Exports?

Port	Shipments	% Share
SAHAR AIR	165	14.4%
SAHAR AIR CARGO ACC (INBOM4)	127	11.1%
DELHI AIR	71	6.2%
NHAVA SHEVA SEA (INNSA1)	59	5.1%
DELHI AIR CARGO ACC (INDEL4)	59	5.1%
Bombay Air	57	5.0%
JNPT/ NHAVA SHEVA SEA	46	4.0%
MUNDRA SEA (INMUN1)	43	3.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Vildagliptin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vildagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 31 individual customs records matching SUN Pharmaceutical Industries Limited exporting Vildagliptin, covering 23 formulations to 5 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 87+ countries, 304+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vildagliptin

Vildagliptin

SUN Pharmaceutical Industries Limited — Vildagliptin Exporter Profile

SUN Pharmaceutical Industries Limited — Vildagliptin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Vildagliptin?

Who Are the Top Buyers of Vildagliptin from SUN Pharmaceutical Industries Limited?

What Is India's Total Vildagliptin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Vildagliptin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Vildagliptin Exporters?

What Vildagliptin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Vildagliptin to Key Markets

Brazil — ANVISA

South Africa — SAHPRA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Vildagliptin Exporters?

Which Indian Ports Ship Vildagliptin Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Vildagliptin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vildagliptin Export Data from SUN Pharmaceutical Industries Limited

Vildagliptin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source